Spoke with Vicki Clemens of NanosomiX today. Their AZ test is a non-surrogate upstream neuron derived exosome test for both Tau plaque and A-beta. She confirmed they are launching this month and will be at JP Morgan Conference. She indicated they are seeking funding via PP, VC or Angels. Interesting conversation when you have a chance for further discussion. She did say they've received huge interest from the BP community, and that they are excited about LymPros debut this month as well.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links